Effectiveness of BNT162b2 mRNA COVID-19 vaccine against SARS-CoV-2 variant Beta (B.1.351) among persons identified through contact tracing in Israel: A prospective cohort study

BACKGROUND: SARS-CoV-2 variant Beta (B.1.351) was designated as a Variant of Concern (VoC) after becoming the dominant strain in South Africa and spreading internationally. BNT162b2 showed lower levels of neutralizing antibodies against Beta than against other strains raising concerns about effectiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Singer, Shepherd R., Angulo, Frederick J., Swerdlow, David L., McLaughlin, John M., Hazan, Itay, Ginish, Netanel, Anis, Emilia, Mendelson, Ella, Mor, Orna, Zuckerman, Neta S, Erster, Oran, Southern, Jo, Pan, Kaijie, Mircus, Gabriel, Lipsitch, Marc, Haas, Eric J., Jodar, Luis, Levy, Yeheskel, Alroy-Preis, Sharon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Research paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8628463/
https://www.ncbi.nlm.nih.gov/pubmed/34870134
http://dx.doi.org/10.1016/j.eclinm.2021.101190

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8628463/
https://www.ncbi.nlm.nih.gov/pubmed/34870134
http://dx.doi.org/10.1016/j.eclinm.2021.101190

Ejemplares similares